Champions Oncology Inc (OTCMKTS:CSBR) President Ronnie Morris bought 10,305 shares of the stock in a transaction on Friday, October 14th. The shares were bought at an average price of $1.66 per share, for a total transaction of $17,106.30. Following the purchase, the president now directly owns 1,061,347 shares in the company, valued at approximately $1,761,836.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Ronnie Morris also recently made the following trade(s):

  • On Thursday, October 13th, Ronnie Morris bought 29,695 shares of Champions Oncology stock. The shares were bought at an average price of $1.67 per share, for a total transaction of $49,590.65.
  • On Monday, October 10th, Ronnie Morris bought 9,537 shares of Champions Oncology stock. The shares were bought at an average price of $1.66 per share, for a total transaction of $15,831.42.
  • On Tuesday, September 20th, Ronnie Morris bought 3,000 shares of Champions Oncology stock. The shares were bought at an average price of $1.58 per share, for a total transaction of $4,740.00.

Champions Oncology Inc (OTCMKTS:CSBR) traded up 1.82% during trading on Monday, reaching $1.68. 90,156 shares of the company’s stock traded hands. Champions Oncology Inc has a one year low of $1.11 and a one year high of $5.46. The firm’s market cap is $18.42 million. The company has a 50 day moving average of $1.65 and a 200 day moving average of $2.55.

Champions Oncology (OTCMKTS:CSBR) last released its quarterly earnings data on Friday, September 9th. The company reported ($0.15) earnings per share for the quarter. The company earned $3.70 million during the quarter.

Insider Buying and Selling by Quarter for Champions Oncology (OTCMKTS:CSBR)

About Champions Oncology

Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.

Receive News & Stock Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related stocks with our FREE daily email newsletter.